Abstract
Aims: The prevalence of islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes mellitus (Type 1 DM) from Sri Lanka is described. Design and Methods: Autoantibodies to glutamic acid decarboxylase 65 (GAD65Ab), protein tyrosine phosphatase IA-2 (IA-2Ab), insulin (IAAb), thyroglobulin (TgAb), thyroid peroxidase (TPOAb), TSH receptor (TRAb), 21-hydroxylase (21-OHAb) and tissue transglutaminase (tTGAb) were measured in 122 Type 1 DM patients who had low C-peptide activity or were >20 yr old at the time of diagnosis and in 100 non-diabetic blood donors. Results: GAD65Ab and/or IA-2Ab were present in 74/122 (60.7%) Type 1 DM subjects with a significantly higher prevalence compared to non-diabetic controls (no. 100) (GAD65Ab-59 vs 4%; IA-2Ab-14 vs 0%; respectively) (p<0.001). The median (inter-quartile range) Type 1 DM duration in antibody positive subjects was 3.3 (0.99-6.9) vs 4.9 (1.7–7.5) yr in antibody negative subjects (p=0.23). IA-2Ab prevalence decreased with disease duration ≥5 yr (19 vs 4%) (p<0.001). There was no difference in the prevalence of TgAb (25 vs 33%)(p=0.21) and TPOAb (22 vs 18%) (p=0.48) in Type 1 DM and non-diabetic subjects. Also, there was no difference in TgAb and TPOAb prevalence in antibody positive Type 1 DM (34.7%) compared to antibody negative Type 1 DM (24.4%) subjects (p=0.24). tTGAb (3/119) and TRAb (1/119) were found in low prevalence and 21-OHAb were not detected. Conclusions: Diabetes associated autoantibodies were detected in the majority of Type 1 DM subjects, suggesting a major role for autoimmunity in the pathogenesis of Type 1 DM in Sri Lankans. The prevalence of TgAb and TPOAb in Type 1 DM subjects and non-diabetic controls was relatively high and similar in both groups.
Similar content being viewed by others
References
Lernmark A, Falorni A. Immunology of insulin dependent diabetes mellitus. In: Pickup J, Williams G eds. Textbook of Diabetes. London: Blackwell. 1999, 15.1–15.23.
Redondo MJ, Eisenbarth GS. Genetic control of autoimmunity in Type 1 diabetes and associated disorders. Diabetologia 2002, 45: 605–22.
Zimmet PZ, Rowley MJ, Mackay JR, et al. The ethnic distribution of antibodies to glutamicacid decarboxylase: presence and levels in insulin dependent diabetes mellitus in Europid and Asian subjects. J Diabetes Complications 1993, 7: 1–7.
Todd AL, Ng WY, Lui KF, Thai AC. Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics. Intern Med J 2004, 34: 24–30.
Verge CF, Gianani R, Kawasaki E, et al. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45: 926–33.
Genovese S, Bonfanti R, Bazigaluppi E, et al. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996, 39: 1223–6.
Kalmala P, Savola K, Peterson JS, et al. Prediction of insulin dependent diabetes mellitus in siblings of children with diabetes; a population study. J Clin Invest 1998, 101: 327–36.
Velloso LA, Kampe O, Hallberg A, Chrismanson L, Betsholtz C, Karlsson FA. Demonstration of GAD65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 1993, 91: 2084–90.
Atkinson MA, Eisenbarth GS. Type 1 diabetes; new perspectives on disease pathogenesis and treatment. Lancet 2001, 358: 221–9.
Betterle C, Lazzarotto F, Presotto E. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin Exp Immunol 2004, 137: 225–33.
Betterle C, Volpato M, Rees-Smith B. Adrenal cortex and steroid 21 hydroxylase autoantibodies in children with organ-specific autoimmune disease: markers of high progression to clinical Addison’s disease. J Clin Endocrinol Metab 1997, 82: 939–42.
Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Hui RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes; a multicenter survey. Diabetes Care 2002, 25: 1346–50.
Franseze A, Buono P, Mascolo M, Leo AL, Valerio G. Thyroid autoimmunity starting during the course of type 1 diabetes denotes a subgroup of children with more severe diabetes. Diabetes Care 2000, 23: 1201–2.
Jaeger C, Hatziagelake E, Petzoldt E, Bretzel RG. Comparative analysis of organ specific autoantibodies and celiac disease associated antibodies in type 1 diabetic patients, their first-degree relatives and healthy control subjects. Diabetes Care 2001, 24: 27–32.
Premawardhana LD, Parkes AB, Smyth PP, et al. Increased prevalence of thyroglobulin antibodies in Sri Lankan schoolgirls — is iodine the cause? Eur J Endocrinol 2000, 143: 185–8.
Mazziotti G, Premawardhana LD, Parkes AB, et al. Evolution of thyroid autoimmunity during iodine prophylaxis — the Sri Lankan experience. Eur J Endocrinol 2003, 149: 1003–110.
Smyth PPA, Wijeyaratne CN, Kaluarachi WN, et al. Sequential studies on thyroid antibodies during pregnancy. Thyroid 2005, 15: 474–7.
Bournaud C, Orgiazzi JJ. Iodine excess and thyroid autoimmunity. Endocrinol Invest 2003, 26 (Suppl 2): 49–56.
Premawardhana LDKE, Parkes AB, Mazziotti G, Lazarus JH. Autoimmune thyroiditis after elimination of iodine deficiency in Sri Lanka. Thyroid 2004, 13: 1187–8.
Brooking H, Ananieva-Jordanova R, Arnold C, et al. A sensitive non-isotopic assay for GAD65 autoantibodies. Clin Chim Acta 2003, 331: 55–9.
Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin dependant diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta 2000, 291: 53–6.
Tanaka H, Perez MS, Powell M, et al. Steroid 21-hydroxylase autoantibodies; measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab 1997, 82: 1440–6.
Nakachi K, Swift G, Wilmot D, et al. Antibodies to tissue transglutaminase; comparison of ELISA and immunoprecipitation assay in the presence and in the absence of calcium ions. Clin Chim Acta 2001, 304: 75–84.
Beever K, Bradbury J, Phillips D, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989, 35: 1949–54.
Rees Smith B, Bolton J, Young S, et al. A new assay for thyrotrophin receptor antibodies. Thyroid 2004, 14: 830–5.
Falorni A, Brozzetti A. Diabetes related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005, 19: 119–33.
Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM; a population based study. Diabetologia 1994, 37: 1113–20.
Vanderwalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG, Gorus FK. Belgian Diabetes Register. High diagnostic sensitivity of glutamate decarboxylase autoantibodiesin insulin dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995, 80: 846–51.
Kochum I, Lerbnark A, Dahlquist G, et al. The Swedish Childhood Diabetes Study Group, The Diabetes incidence in Sweden Study (DISS) Group. Genetic and immunological findings in patients with newly diagnosed insulin dependent diabetes mellitus. Horm Metab Res 1996, 28: 344–7.
Batstra MR, Pina M, Quan J, et al. Fluctuation in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 1997, 20: 642–4.
Chuang LM, Lin CY, Wu HP, Tsai WY, Tai TY, Lin BJ. Anti GAD65 autoantibody in Taiwanese patients with insulin dependent diabetes mellitus: effect of HLA on anti GAD positivity and clinical characteristics. Clin Endocrinol (Oxf)1997, 47: 455–61.
Borg H, Marcus C, Sjoblad S, Fernlund P, Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Acta Paediatr 2000, 89: 46–51.
Marita AR, Rane S, Mokal RA, Nair SR, Irani A. Autoantibodies against GAD65 and IA-2 in recently diagnosed Type 1 diabetic children from Western India. Diabet Med 2004, 21: 956–7.
Sanjeevi CB, Shautevete A, Ramachandran A, Snehalatha C, Falorni A. Prevalence of GAD65 autoantibodies in South Indian patients with insulin dependent diabetes mellitus and in their parents. Diabetes, Nutr Metab 1997, 10: 60–4.
Goswami R, Kochupillai N, Gupta N, Kukreja A, Lan M, Maclaren NK. Islet cell autoimmunity in youth onset diabetes mellitus in Northern India. Diabetes Res Clin Pract 2001, 53: 47–54.
Singh AK, Bhatia E, Dabadghao P, Bhatia V, Gellert SA, Colman PG. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians. Diabet Med 2000, 17: 275–80.
Nazaimoon WM, Azmi KN, Rasat R, et al. Autoimmune markers in young Malaysian patients with type 1 diabetes mellitus. Med J Malaysia 2000, 55: 318–23.
Davis TM, Mehta Z, Mackay IR, et al. Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes. Diabet Med 2003, 20: 198–204.
Onkamo P, Vaananen S, Karvonen M, Tuomehlito J. Worldwide increase in type 1 diabetes — the analysis of the data on published incidence trends. Diabetologia 1999, 42: 1395–403.
Tuomilehto J, Karvonen M, Pitkaniemi J, et al. Record high incidence of type 1 diabetes mellitus in Finnish children. The Finnish Childhood type 1 Diabetes Registry Group. Diabetologia 1999, 42: 655–60.
Karvonen M, Viik-Kajander M, Moltchanova E, Libman J, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (Dia Mond) Project group. Diabetes Care 2000, 23: 1516–26.
Ko KW, Yang SW, Cho NH. The incidence of IDDM in Seoul from 1985 to 1988. Diabetes Care 1994, 17: 1473–5.
Lee WW, Ooi BC, Thai AC, et al. The incidence of IDDM in Singapore children. Singapore Med J 1998, 39: 359–62.
Okosieme OE, Premawardhana LDKE, Jayasinghe A, et al. Thyroglobulin autoantibodies in iodised subjects; relationship between epitope specificities and longitudinal activity. Thyroid 2005, 15: 1067–72.
Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001, 14: 279–86.
Kordunouri O, Klindhammer A, Lang EB, Gruters Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes; a multicentre survey. Diabetes Care 2002, 25: 1346–50.
Chang CC, Huang CN, Chuang LM. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 1998, 139: 44–8.
Barova H, Perusicova J, Hill M, Sterzl I, Vondra K, Masek Z. Anti GAD positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD negative patients with type 1 and type 2 diabetes mellitus. Physiol Rev 2004, 53: 279–86.
Presotto F, Betterle C. Insulin-dependent diabetes mellitus: a constellation of autoimmune diseases. J Ped Endocrinol Metab 1997, 10: 455–69.
Barker JM, Ide A, Hostetler C, et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison’s disease in a high-risk population. J Clin Endocrinol Metab 2005, 90: 128–34.
Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002, 23: 327–64.
Coco G, Dal Pra C, Presotto F, et al. Estimated risk for developing autoimmune Addison’s disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006, 91: 1637–45.
Nigam R, Bhatia E, Miao D, et al. Prevalence of adrenal antibodies in Addison’s disease among north Indian Caucasians. Clin Endocrinol (Oxf) 2003, 59: 593–8.
Falorni A, Laureti S. Adrenal autoimmunity and correlation with adrenal dysfunction. Endocrinologist 2000, 10: 145–54.
Liu E, Eisenbarth GS. Type 1 diabetes mellitus associated autoimmunity. Endocrinol Metab Clin North Am 2002, 31: 391–410.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Premawardhana, L.D.K.E., Wijeyaratne, C.N., Chen, S. et al. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka. J Endocrinol Invest 29, 968–974 (2006). https://doi.org/10.1007/BF03349209
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349209